133 related articles for article (PubMed ID: 36721313)
1. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia.
Zhang X; Gleber-Netto FO; Wang S; Martins-Chaves RR; Gomez RS; Vigneswaran N; Sarkar A; William WN; Papadimitrakopoulou V; Williams M; Bell D; Palsgrove D; Bishop J; Heymach JV; Gillenwater AM; Myers JN; Ferrarotto R; Lippman SM; Pickering CR; Xiao G
Cancer Med; 2023 Mar; 12(6):7508-7518. PubMed ID: 36721313
[TBL] [Abstract][Full Text] [Related]
2. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM
J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
5. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
6. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
7. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
9. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
10. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
14. Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients.
Zarate AM; Don J; Secchi D; Carrica A; Galindez Costa F; Panico R; Brusa M; Barra JL; Brunotto M
Tumour Biol; 2017 May; 39(5):1010428317699113. PubMed ID: 28459200
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
16. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.
Chaturvedi AK; Udaltsova N; Engels EA; Katzel JA; Yanik EL; Katki HA; Lingen MW; Silverberg MJ
J Natl Cancer Inst; 2020 Oct; 112(10):1047-1054. PubMed ID: 31860085
[TBL] [Abstract][Full Text] [Related]
17. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach.
Bhattacharyya S; Ray S; Saha D; Mustafi SM; Alam N; Sarkar A; Murmu N
Pathol Res Pract; 2021 Feb; 218():153287. PubMed ID: 33454586
[TBL] [Abstract][Full Text] [Related]
18. Histological grading of oral epithelial dysplasia: revisited.
Warnakulasuriya S
J Pathol; 2001 Jul; 194(3):294-7. PubMed ID: 11439360
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
20. Oral epithelial dysplasia detection and grading in oral leukoplakia using deep learning.
Peng J; Xu Z; Dan H; Li J; Wang J; Luo X; Xu H; Zeng X; Chen Q
BMC Oral Health; 2024 Apr; 24(1):434. PubMed ID: 38594651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
